Procter & Gamble Stock May Be Undervalued by as Much as 24%

Procter & Gamble's stock price has been under scrutiny after its Q1 sales slipped, sparking questions about whether it is undervalued. The company's 22.1% total return over the past five years puts its current share price of $149 into focus.

A Discounted Cash Flow (DCF) model suggests that Procter & Gamble's estimated intrinsic value is meaningfully above its current market price. This model takes into account the company's free cash flow, which has been steadily growing over the past decade.

However, recent commentary from Procter & Gamble Hygiene and Health Care on softer sales in India, shifting demand, and commodity cost volatility highlights the challenges facing the company. The bear case for Procter & Gamble suggests that it may be 39% overvalued, while the bull case sees the stock as roughly fairly valued.

The valuation of Procter & Gamble is a complex issue, with different views on its intrinsic value and potential growth prospects. The company's recent insider selling has also been flagged for attention.